Jump to section
IdentificationPharmacologyInteractionsReferencesTrialsEconomicsPropertiesSpectraTaxonomyButyric Acid
Identification
- Name
- Butyric Acid
- Accession Number
- DB03568 (EXPT00774)
- Type
- Small Molecule
- Groups
- Experimental, Investigational
- Description
A four carbon acid, CH3CH2CH2COOH, with an unpleasant odor that occurs in butter and animal fat as the glycerol ester.
- Structure
- Synonyms
- 1-propanecarboxylic acid
- Butanoic acid
- Butyrate
- Butyricum acidum
- Ethylacetic acid
- N-butanoic acid
- N-butyric acid
- Propylformic acid
- External IDs
- FEMA NO. 2221 / NSC-8415
- Categories
- UNII
- 40UIR9Q29H
- CAS number
- 107-92-6
- Weight
- Average: 88.1051
Monoisotopic: 88.0524295 - Chemical Formula
- C4H8O2
- InChI Key
- FERIUCNNQQJTOY-UHFFFAOYSA-N
- InChI
- InChI=1S/C4H8O2/c1-2-3-4(5)6/h2-3H2,1H3,(H,5,6)
- IUPAC Name
- butanoic acid
- SMILES
- CCCC(O)=O
Pharmacology
- Indication
- Not Available
- Pharmacodynamics
- Not Available
- Mechanism of action
Target Actions Organism UCholinesterase Not Available Humans U2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase Not Available Pseudomonas fluorescens U(S)-2-haloacid dehalogenase Not Available Pseudomonas sp. (strain YL) - Absorption
- Not Available
- Volume of distribution
- Not Available
- Protein binding
- Not Available
- Metabolism
- Not Available
- Route of elimination
- Not Available
- Half life
- Not Available
- Clearance
- Not Available
- Toxicity
- Not Available
- Affected organisms
- Not Available
- Pathways
Pathway Category Butyrate Metabolism Metabolic Fatty Acid Biosynthesis Metabolic Fatty Acid Biosynthesis Metabolic Fatty Acid Oxidation (Butanoate) Metabolic Butyrate Metabolism Metabolic Fatty Acid Biosynthesis Metabolic - Pharmacogenomic Effects/ADRs
- Not Available
Interactions
References
- Synthesis Reference
Haruhiko Kikuchi, "Process for preparing 4-(4-biphenylyl)-4-oxo-butanoic acid." U.S. Patent US4621154, issued November, 1977.
US4621154- General References
- Not Available
- External Links
- Human Metabolome Database
- HMDB0000039
- KEGG Compound
- C00246
- PubChem Compound
- 264
- PubChem Substance
- 46505927
- ChemSpider
- 259
- BindingDB
- 26109
- ChEBI
- 30772
- ChEMBL
- CHEMBL14227
- IUPHAR
- 1059
- Guide to Pharmacology
- GtP Drug Page
- HET
- BUA
- Wikipedia
- Butyric_acid
- PDB Entries
- 1p0i / 1ugp / 1uk7 / 1zrm / 2cz0 / 2cz1 / 2ha7 / 2j4c / 3dlt / 3i3f … show 9 more
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 0 Completed Treatment Ataxia Telangiectasia (AT) 1 Not Available Completed Basic Science Visceral (Hyper)Sensitivity 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
Property Value Source melting point (°C) -5.7 °C PhysProp boiling point (°C) 163.7 °C PhysProp water solubility 6E+004 mg/L (at 25 °C) HEMPHILL,L & SWANSON,WS (1964) logP 0.79 HANSCH,C ET AL. (1995) logS -0.19 ADME Research, USCD pKa 4.82 (at 25 °C) RIDDICK,JA ET AL. (1986) - Predicted Properties
Property Value Source Water Solubility 239.0 mg/mL ALOGPS logP 0.78 ALOGPS logP 0.92 ChemAxon logS 0.43 ALOGPS pKa (Strongest Acidic) 4.91 ChemAxon Physiological Charge -1 ChemAxon Hydrogen Acceptor Count 2 ChemAxon Hydrogen Donor Count 1 ChemAxon Polar Surface Area 37.3 Å2 ChemAxon Rotatable Bond Count 2 ChemAxon Refractivity 21.87 m3·mol-1 ChemAxon Polarizability 9.22 Å3 ChemAxon Number of Rings 0 ChemAxon Bioavailability 1 ChemAxon Rule of Five Yes ChemAxon Ghose Filter No ChemAxon Veber's Rule Yes ChemAxon MDDR-like Rule No ChemAxon - Predicted ADMET features
Property Value Probability Human Intestinal Absorption + 0.9938 Blood Brain Barrier + 0.9572 Caco-2 permeable + 0.7456 P-glycoprotein substrate Non-substrate 0.759 P-glycoprotein inhibitor I Non-inhibitor 0.9554 P-glycoprotein inhibitor II Non-inhibitor 0.9773 Renal organic cation transporter Non-inhibitor 0.9544 CYP450 2C9 substrate Non-substrate 0.8026 CYP450 2D6 substrate Non-substrate 0.9177 CYP450 3A4 substrate Non-substrate 0.7582 CYP450 1A2 substrate Inhibitor 0.5106 CYP450 2C9 inhibitor Non-inhibitor 0.9345 CYP450 2D6 inhibitor Non-inhibitor 0.9519 CYP450 2C19 inhibitor Non-inhibitor 0.9613 CYP450 3A4 inhibitor Non-inhibitor 0.972 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.9849 Ames test Non AMES toxic 0.95 Carcinogenicity Non-carcinogens 0.5611 Biodegradation Ready biodegradable 0.9659 Rat acute toxicity 1.6755 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9484 hERG inhibition (predictor II) Non-inhibitor 0.9677
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Taxonomy
- Description
- This compound belongs to the class of organic compounds known as straight chain fatty acids. These are fatty acids with a straight aliphatic chain.
- Kingdom
- Organic compounds
- Super Class
- Lipids and lipid-like molecules
- Class
- Fatty Acyls
- Sub Class
- Fatty acids and conjugates
- Direct Parent
- Straight chain fatty acids
- Alternative Parents
- Monocarboxylic acids and derivatives / Carboxylic acids / Organic oxides / Hydrocarbon derivatives / Carbonyl compounds
- Substituents
- Straight chain fatty acid / Monocarboxylic acid or derivatives / Carboxylic acid / Carboxylic acid derivative / Organic oxygen compound / Organic oxide / Hydrocarbon derivative / Organooxygen compound / Carbonyl group / Aliphatic acyclic compound
- Molecular Framework
- Aliphatic acyclic compounds
- External Descriptors
- straight-chain saturated fatty acid, short-chain fatty acid (CHEBI:30772) / Straight chain fatty acids, Saturated fatty acids (C00246) / Straight chain fatty acids (LMFA01010004)
Targets
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Identical protein binding
- Specific Function
- Esterase with broad substrate specificity. Contributes to the inactivation of the neurotransmitter acetylcholine. Can degrade neurotoxic organophosphate esters.
- Gene Name
- BCHE
- Uniprot ID
- P06276
- Uniprot Name
- Cholinesterase
- Molecular Weight
- 68417.575 Da
- Kind
- Protein
- Organism
- Pseudomonas fluorescens
- Pharmacological action
- Unknown
- General Function
- Hydrolase activity
- Specific Function
- Not Available
- Gene Name
- cumD
- Uniprot ID
- P96965
- Uniprot Name
- 2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase
- Molecular Weight
- 31489.385 Da
- Kind
- Protein
- Organism
- Pseudomonas sp. (strain YL)
- Pharmacological action
- Unknown
- General Function
- (s)-2-haloacid dehalogenase activity
- Specific Function
- Catalyzes the hydrolytic dehalogenation of small (S)-2-haloalkanoic acids to yield the corresponding (R)-2-hydroxyalkanoic acids. Acts on acids of short chain lengths, C(2) to C(4), with inversion ...
- Gene Name
- Not Available
- Uniprot ID
- Q53464
- Uniprot Name
- (S)-2-haloacid dehalogenase
- Molecular Weight
- 26176.335 Da
References
- Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed:17139284]
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed:17016423]
Enzymes
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Identical protein binding
- Specific Function
- Esterase with broad substrate specificity. Contributes to the inactivation of the neurotransmitter acetylcholine. Can degrade neurotoxic organophosphate esters.
- Gene Name
- BCHE
- Uniprot ID
- P06276
- Uniprot Name
- Cholinesterase
- Molecular Weight
- 68417.575 Da
Drug created on June 13, 2005 07:24 / Updated on November 02, 2018 05:37